United Therapeutics (UTHR) Tops Q3 EPS by 57c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $544.33 +1.12%
Revenue Growth %: +1.5%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +1.5%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $4.16, $0.57 better than the analyst estimate of $3.59. Revenue for the quarter came in at $444.7 million versus the consensus estimate of $421.45 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Green Dot and CommerceOne shareholders approve acquisition deal
- Cerebras Q1 EPS miss sends shares down 9% after-hours
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
